Ainos (AIMD) Competitors $0.62 -0.01 (-1.88%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AIMD vs. ESLA, CASI, RAPT, ITRM, BRNS, TPST, ELEV, CLDI, ANVS, and IXHLShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Estrella Immunopharma (ESLA), CASI Pharmaceuticals (CASI), RAPT Therapeutics (RAPT), Iterum Therapeutics (ITRM), Barinthus Biotherapeutics (BRNS), Tempest Therapeutics (TPST), Elevation Oncology (ELEV), Calidi Biotherapeutics (CLDI), Annovis Bio (ANVS), and Incannex Healthcare (IXHL). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Estrella Immunopharma CASI Pharmaceuticals RAPT Therapeutics Iterum Therapeutics Barinthus Biotherapeutics Tempest Therapeutics Elevation Oncology Calidi Biotherapeutics Annovis Bio Incannex Healthcare Ainos (NASDAQ:AIMD) and Estrella Immunopharma (NASDAQ:ESLA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends. Does the MarketBeat Community believe in AIMD or ESLA? Estrella Immunopharma received 1 more outperform votes than Ainos when rated by MarketBeat users. CompanyUnderperformOutperformAinosN/AN/AEstrella ImmunopharmaOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation & earnings, AIMD or ESLA? Estrella Immunopharma has lower revenue, but higher earnings than Ainos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$120K72.82-$13.77MN/AN/AEstrella ImmunopharmaN/AN/A-$7.31M-$0.26-5.69 Which has more volatility & risk, AIMD or ESLA? Ainos has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, Estrella Immunopharma has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Do analysts rate AIMD or ESLA? Estrella Immunopharma has a consensus price target of $16.00, indicating a potential upside of 981.08%. Given Estrella Immunopharma's stronger consensus rating and higher probable upside, analysts clearly believe Estrella Immunopharma is more favorable than Ainos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Estrella Immunopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in AIMD or ESLA? 0.4% of Estrella Immunopharma shares are held by institutional investors. 10.4% of Ainos shares are held by insiders. Comparatively, 55.1% of Estrella Immunopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is AIMD or ESLA more profitable? Ainos' return on equity of -75.16% beat Estrella Immunopharma's return on equity.Company Net Margins Return on Equity Return on Assets AinosN/A -75.16% -50.22% Estrella Immunopharma N/A -195.77%-157.28% Does the media prefer AIMD or ESLA? In the previous week, Estrella Immunopharma had 6 more articles in the media than Ainos. MarketBeat recorded 6 mentions for Estrella Immunopharma and 0 mentions for Ainos. Estrella Immunopharma's average media sentiment score of 0.47 beat Ainos' score of 0.00 indicating that Estrella Immunopharma is being referred to more favorably in the news media. Company Overall Sentiment Ainos Neutral Estrella Immunopharma Neutral SummaryEstrella Immunopharma beats Ainos on 9 of the 13 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.90M$7.06B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A5.8226.1519.13Price / Sales72.82268.05435.3370.72Price / CashN/A65.6738.0134.83Price / Book0.126.717.644.62Net Income-$13.77M$138.55M$3.19B$245.94M7 Day Performance-16.08%-2.63%-2.11%-2.62%1 Month Performance-15.25%-2.33%-0.49%-2.15%1 Year Performance-23.55%-5.33%16.44%12.95% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos0.4108 of 5 stars$0.62-1.9%N/A-23.5%$8.90M$120,000.000.0040Gap UpESLAEstrella Immunopharma2.7907 of 5 stars$1.22+8.0%$16.00+1,211.5%+42.3%$41.61MN/A-4.69N/AAnalyst ForecastNews CoverageGap UpCASICASI Pharmaceuticals3.7255 of 5 stars$2.50-3.5%$6.00+140.0%-55.4%$41.52M$33.88M0.00180Gap UpRAPTRAPT Therapeutics4.1936 of 5 stars$1.20+0.8%$5.88+389.6%-87.7%$41.25M$1.53M-0.4380Gap UpITRMIterum Therapeutics2.5972 of 5 stars$1.54+2.7%$5.00+224.7%+3.8%$41MN/A0.0010Short Interest ↓BRNSBarinthus Biotherapeutics2.7984 of 5 stars$1.09+5.3%$5.17+374.0%-61.5%$40.23M$800,000.00-0.73107Gap DownTPSTTempest Therapeutics2.7562 of 5 stars$0.93-0.2%$21.67+2,229.5%-76.4%$39.67MN/A-0.6120ELEVElevation Oncology1.8627 of 5 stars$0.67+1.9%$7.20+971.9%-78.1%$39.63MN/A0.0040CLDICalidi Biotherapeutics1.9905 of 5 stars$1.36+0.7%$16.67+1,125.5%N/A$39.17M$50,000.000.0038Gap UpANVSAnnovis Bio2.0964 of 5 stars$2.73+5.1%$31.40+1,048.9%-79.0%$38.92MN/A-0.613IXHLIncannex Healthcare0.5417 of 5 stars$1.78-1.0%N/A-74.4%$38.81M$10,000.000.003Earnings Report Related Companies and Tools Related Companies ESLA Competitors CASI Competitors RAPT Competitors ITRM Competitors BRNS Competitors TPST Competitors ELEV Competitors CLDI Competitors ANVS Competitors IXHL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIMD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIMD Stock Alerts